NCCN Awards Grants to Advance Research on Elranatamab in Multiple Myeloma Treatment
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced its decision to fund clinical studies focused on the efficacy and safety of elranatamab …
NCCN Awards Grants to Advance Research on Elranatamab in Multiple Myeloma Treatment Read More